Leadership Overview
CenExel Clinical Research has 10 executives leading key functions including site operations, strategic growth, human capital, financial management, and medical oversight.
Committed to advancing medical science through a nationwide network of clinical sites, CenExel Clinical Research delivers premium data and operational excellence to global pharmaceutical partners. This organization prioritizes patient engagement and scientific precision to accelerate complex clinical trial outcomes across the United States.
Committed to advancing medical science through a nationwide network of clinical sites, CenExel Clinical Research delivers premium data and operational excellence to global pharmaceutical partners. This organization prioritizes patient engagement and scientific precision to accelerate complex clinical trial outcomes across the United States.
Leadership Roles at CenExel Clinical Research
Heather Beitz - Chief Executive Officer, CenExel Decatur
Heather Beitz, the Chief Executive Officer, CenExel Decatur at CenExel Clinical Research, directs all site-specific clinical operations within the Decatur facility. Beitz manages the execution of complex clinical trials, ensuring adherence to rigorous scientific protocols and regulatory standards. By optimizing patient recruitment strategies and maintaining high data integrity, the Chief Executive Officer, CenExel Decatur supports the broader mission of the nationwide network. Heather Beitz coordinates with regional leadership to align site performance with corporate objectives, fostering an environment of operational efficiency. This leadership role involves managing local staff, overseeing trial timelines, and ensuring that every participant receives exceptional care throughout the research process. Through meticulous attention to detail and a focus on high-quality data delivery, Beitz drives successful outcomes for pharmaceutical and biotech partners, solidifying the reputation of the Decatur center as a premier hub for clinical excellence.
Ryan Brooks - Executive Chairman & Chief Executive Officer
Ryan Brooks, the Executive Chairman & Chief Executive Officer at CenExel Clinical Research, architects the overarching strategic vision for the entire network of 18 Centers of Excellence. Brooks defines the long-term growth trajectory, identifying opportunities for expansion and technological integration across the United States. As the Executive Chairman & Chief Executive Officer, Ryan Brooks maintains alignment between the Board and the executive team, ensuring that corporate governance supports the delivery of premium clinical research services. This role involves cultivating relationships with major pharmaceutical and biotech organizations to secure high-impact partnerships. By fostering a culture of innovation and operational rigor, Brooks ensures that the network remains at the forefront of the industry. The Executive Chairman & Chief Executive Officer monitors macro-level performance metrics, driving the organization toward sustained financial health and scientific leadership while maintaining the highest standards of patient safety and data quality.
Todd Orullian - Chief Financial Officer
Todd Orullian, the Chief Financial Officer at CenExel Clinical Research, manages the financial health and capital allocation strategies for the organization. Orullian directs all fiscal planning, budgeting, and financial reporting, ensuring that the network maintains the resources necessary to support its 18 Centers of Excellence. As the Chief Financial Officer, Todd Orullian evaluates investment opportunities in new technologies and site expansions, providing the financial rigor required for sustainable growth. This role involves overseeing revenue cycle management and cost-efficiency initiatives to maximize profitability while maintaining high standards of clinical service. By providing transparent financial analysis to the Board and executive leadership, Orullian supports informed decision-making regarding long-term strategic goals. The Chief Financial Officer ensures that the company remains financially resilient, enabling the network to continue delivering premium data and real-world solutions to the world's most results-driven pharmaceutical and biotech organizations.
Bethany Sensenig - Chief Financial Officer & Head of Strategy
Bethany Sensenig, the Chief Financial Officer & Head of Strategy at CenExel Clinical Research, leads the development of long-term strategic initiatives while managing the financial planning and analysis functions. Sensenig identifies market trends and growth opportunities, ensuring that the network's strategic direction aligns with the evolving needs of the pharmaceutical and biotech industries. As the Chief Financial Officer & Head of Strategy, Bethany Sensenig oversees the integration of strategic planning with financial forecasting to drive sustainable expansion. This role involves analyzing competitive landscapes and optimizing the company's business model to enhance service delivery across all 18 Centers of Excellence. By providing strategic guidance to the executive team, Sensenig ensures that the organization remains agile and responsive to market demands. The Chief Financial Officer & Head of Strategy supports the company's mission by balancing financial discipline with innovative growth strategies, ultimately securing the network's position as a premier provider of clinical research solutions.

Daniel Coyle - Chief Operating Officer
Daniel Coyle, the Chief Operating Officer at CenExel Clinical Research, oversees the standardization of operational processes across the entire nationwide network. Coyle directs the implementation of unified site protocols, ensuring that every Center of Excellence maintains consistent quality and efficiency in trial execution. As the Chief Operating Officer, Daniel Coyle manages the integration of new sites into the network, scaling operations to meet the increasing demands of global clinical research organizations. This role involves optimizing resource allocation, improving patient engagement workflows, and reducing trial timelines through data-driven operational improvements. By monitoring performance metrics across all metropolitan locations, Coyle ensures that the network delivers reliable, high-quality data to pharmaceutical partners. The Chief Operating Officer collaborates with medical and financial leadership to align operational capacity with strategic growth targets, ultimately driving the success of complex clinical trials and reinforcing the company's position as a leader in the research industry.
Sarah Kazmi - Chief Operating Officer, Cenexel (Hollywood)
Sarah Kazmi, the Chief Operating Officer, Cenexel (Hollywood) at CenExel Clinical Research, leads the operational activities and site-specific performance for the Hollywood location. Kazmi manages the daily execution of clinical trials, ensuring that the facility meets all regulatory requirements and scientific benchmarks. As the Chief Operating Officer, Cenexel (Hollywood), Sarah Kazmi focuses on optimizing local patient recruitment and retention strategies to ensure trial success. This role involves coordinating with clinical staff to maintain high data quality and operational efficiency within the Hollywood center. By implementing best practices and fostering a culture of excellence, Kazmi contributes to the overall success of the nationwide network. The Chief Operating Officer, Cenexel (Hollywood) collaborates with corporate leadership to align local site performance with broader organizational goals, ensuring that the Hollywood facility remains a key contributor to the company's mission of delivering superior clinical research outcomes.
Thomas Shiovitz - Founder & President
Thomas Shiovitz, the Founder & President at CenExel Clinical Research, provides the foundational vision and leadership that guides the network's commitment to clinical excellence. Shiovitz directs the long-term mission of the organization, ensuring that the network continues to deliver deep scientific expertise and premium data to global partners. As the Founder & President, Thomas Shiovitz maintains the core values of the company, fostering a culture of innovation and patient-centric research. This role involves advising on strategic initiatives and supporting the executive team in maintaining the network's reputation as a leader in the clinical research industry. By leveraging decades of experience, Shiovitz ensures that the organization remains focused on delivering real-world solutions for complex trials. The Founder & President collaborates with leadership to drive the company's growth and influence, ensuring that the network continues to set the standard for quality and efficiency in clinical research across the United States.

Erin Monteverdi - Chief of Staff
Erin Monteverdi, the Chief of Staff at CenExel Clinical Research, manages the internal communication flow and strategic alignment across all executive functions. Monteverdi facilitates cross-departmental collaboration, ensuring that the leadership team executes corporate initiatives with precision and speed. As the Chief of Staff, Erin Monteverdi optimizes the daily operations of the executive office, prioritizing critical projects that impact the network's 18 Centers of Excellence. This role involves synthesizing complex data from various departments to provide actionable insights for the Chief Executive Officer and the Board. By streamlining decision-making processes and managing high-priority administrative workflows, Monteverdi enhances the overall efficiency of the organization. The Chief of Staff acts as a central point of contact for strategic planning, ensuring that every department remains focused on delivering superior clinical trial outcomes and maintaining the company's competitive edge in the highly demanding pharmaceutical research market.
Kristine Meade - Chief Human Resources Officer
Kristine Meade, the Chief Human Resources Officer at CenExel Clinical Research, directs the talent acquisition, employee development, and organizational culture initiatives across the entire network. Meade architects programs that attract and retain top-tier scientific and clinical talent, ensuring that every Center of Excellence remains staffed with highly skilled professionals. As the Chief Human Resources Officer, Kristine Meade oversees performance management systems and leadership training to support the growth of the workforce. This role involves fostering an inclusive and high-performance environment that aligns with the company's mission of delivering exceptional clinical research. By managing compensation, benefits, and employee engagement strategies, Meade ensures that the organization maintains a competitive advantage in the labor market. The Chief Human Resources Officer collaborates with executive leadership to align human capital strategies with the company's long-term operational and financial objectives, driving organizational success through a dedicated and expert team.
Kyle Coupe - Chief Medical Officer
Kyle Coupe, the Chief Medical Officer at CenExel Clinical Research, directs the scientific and medical integrity of all clinical trials conducted across the network. Coupe oversees the implementation of medical protocols, ensuring that every study adheres to the highest ethical and scientific standards. As the Chief Medical Officer, Kyle Coupe provides clinical guidance to site investigators and staff, maintaining the quality of data delivered to pharmaceutical and biotech partners. This role involves monitoring patient safety and ensuring that all research activities comply with regulatory requirements. By fostering a culture of scientific excellence, Coupe ensures that the network remains a trusted partner for complex clinical trials. The Chief Medical Officer collaborates with operational leadership to integrate medical expertise into site workflows, driving the delivery of premium, real-world solutions. Through rigorous oversight and clinical leadership, Coupe supports the company's commitment to advancing medical science and improving patient outcomes.
Explore Leadership Teams in Business Services
Industrial Technology Research Institute (ITRI) is one of the world's leading technology R&D institutions aiming to innovate a better future for society. Founded in 1973, ITRI has played a vital role in transforming Taiwan's industries from labor-intensive into innovation-driven. To address market needs and global trends, it has launched its 2030 Technology Strategy & Roadmap and focuses on innovation development in Smart Living, Quality Health, and Sustainable Environment. It also strives to strengthen Intelligentization Enabling Technology to support diversified applications. Over the years, ITRI has been dedicated to incubating startups and spinoffs, including well-known names such as UMC and TSMC. In addition to its headquarters in Taiwan, ITRI has branch offices in the U.S., Europe, and Japan in an effort to extend its R&D scope and promote international cooperation across the globe.
Company Leadership EC
CW
MT
Crinetics is a pharmaceutical company that develops much-needed therapies for people with endocrine diseases. they are here for patients who are eager to find therapies that provide effective disease control and more simplicity in their lives. they partner with healthcare practitioners to ensure they're solving real problems for them. And they build value in the company for investors by filling real market needs. The company's in-house R&D team of experienced drug discovery scientists develops transformative novel molecules with a focus on the endocrine system and G protein-coupled receptors (GPCRs). Its pipeline is strategically designed to deliver innovative therapies.
Company Leadership NL
RM

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits.
Company Leadership TB
MS
JR
Nova Biomedical is a privately held medical device company headquartered in Waltham, Massachusetts, specializing in the development, manufacturing, and commercialization of advanced analytical instruments and consumables for the biopharmaceutical and clinical markets. Renowned for its innovative in vitro diagnostic devices, the company offers a diverse portfolio that includes critical care blood gas analyzers, point-of-care meters, and cell culture monitoring systems. With a global presence, Nova Biomedical is committed to enhancing patient care and accelerating biopharmaceutical development through cutting-edge technology and dedicated customer service.
Company Leadership


PS